Published online before print January 4, 2007, doi: 10.1161/01.ATV.0000257148.01384.7d
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2007 American Heart Association, Inc.
Vascular Biology |
Stem Cell Factor Attenuates Vascular Smooth Muscle Apoptosis and Increases Intimal Hyperplasia After Vascular Injury
From the Division of Cardiology, Department of Internal Medicine (C.-H.W., I.-C.H., A.H., T.-T.C., S.-Y.W., Y.-C.L., W.-J.C.), Chang Gung Memorial Hospital, Keelung; Chang Gung University College of Medicine, Taiwan; the Division of Cardiac Surgery (S.V.), St. Michael’s Hospital, Toronto, Canada; the Division of Cardiac Surgery (C.-H.W., S.V., R.D.W., R.-K.L.), Toronto General Hospital, Toronto, Canada; the Institute of Bioscience and Biotechnology (T.-T.C.), National Taiwan Ocean University; and the Institute of Biomaterials and Biomedical Engineering (W.L.S.), University of Toronto; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada.
Correspondence to Chao-Hung Wang, MD, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, 222 Mai Chin Road, Keelung, Taiwan. E-mail bearty{at}adm.cgmh.org.tw
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Objective— Stem cell factor (SCF) through its cognate receptor, the tyrosine kinase c-kit, promotes survival and biological functions of hematopoietic stem cells and progenitors. However, whether SCF/c-kit interactions exacerbate intimal hyperplasia through attenuating VSMC apoptosis induced by vascular injury has not been thoroughly investigated.
Methods and Results— VSMCs were stimulated with serum deprivation and H2O2 to induce apoptosis. The transcription of c-kit mRNA and the expression of the c-kit protein by VSMCs were estimated by Q-polymerase chain reaction and Western blotting, respectively. The interactions of SCF and c-kit were investigated by in vitro and in vivo experiments. In vitro, H2O2 stimulation significantly induced apoptosis of VSMCs as evidenced by the 3- and 3.2-fold increases of cleaved caspase-3 compared with those in the control group by Western blot and flow cytometric analyses, respectively (P<0.01). Stimulation of apoptosis also caused 3.5- and 9-fold increases in c-kit mRNA transcription and protein expression, respectively, by VSMCs compared with those in the control group. Administration of SCF (10 to 1000 ng/mL) significantly lowered the amount of cleaved caspase-3 in H2O2-treated VSMCs (P<0.01). Specifically, SCF exerted this effect through activating Akt, followed by increasing Bcl-2 and then inhibiting the release of cytochrome-c from the mitochondria to the cytosol. In vivo, the mouse femoral artery was injured with a wire in SCF mutant (Sl/Sld), c-kit mutant (W/Wv), and colony control mice. In colony control mice, confocal microscopy demonstrated that the wire-injury generated a remarkable activation of caspase-3 on medial VSMCs, coinciding with upregulation of c-kit expression. The wire-injury also caused an increase in the expression of SCF on surviving medial VSMCs and cells in the adventitia. The upregulated c-kit expression in the vessel wall also facilitated homing by circulating SCF+ cells. Compared with colony control mice, vascular injury in SCF mutant and c-kit mutant mice caused a higher number of apoptotic VSMCs on day 14 and a lower number of proliferating cells, and resulted in significantly less neointimal formation (P<0.01) on day 28.
Conclusions— The interactions between SCF and the c-kit receptor play an important role in protecting VSMCs against apoptosis and in maintaining intimal hyperplasia after vascular injury.
Apoptotic stimulation of VSMCs upregulated c-kit mRNA transcription and c-kit protein expression, which attracted SCF-positive cells, thus contributing to neointimal formation. The SCF attenuated the apoptosis of VSMCs through the Akt–Bcl-2 pathway. This study demonstrated that the SCF/c-kit system protects VSMCs against apoptosis and maintained intimal hyperplasia after vascular injury.
Key Words: apoptosis • c-kit tyrosine kinase • intimal hyperplasia • restenosis • stem cell factor
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Neointimal formation, with resultant vascular remodeling, is a unifying pathological event complicating chronic atherosclerosis, restenosis, and transplant arteriopathy, and remains the major limiting factor for the long-term efficacy of vascular interventions, such as angioplasty and coronary artery bypass graft surgery.1,2 VSMC proliferation coincides with apoptosis in vessels undergoing angioplasty.3 The consequences of early-onset apoptosis in medial VSMCs after vascular injury and late apoptosis in the neointima have not been fully investigated. Although it plays an important role in limiting neointimal growth and the subsequent intimal hyperplasia, it may also exacerbate neointima formation at later time points by provoking a greater wound-healing response in an effort to overcome the cellular deficit.4,5
Stem cell factor (SCF, Steel Factor) through its cognate receptor, the tyrosine kinase c-kit,6 promotes survival,7 proliferation,8 mobilization,9 and adhesion10 of hematopoietic stem cells and their progenitors. Recently, the existence of this system has also been demonstrated in the vasculature.11,12 However, the role of its function in atherosclerosis is poorly understood. In this study, we hypothesized that early-onset apoptosis in medial VSMCs after vascular injury activates the SCF/c-kit system, which protects VSMCs from apoptosis and contributes to over-growth of the neointima.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
An expanded Materials and Methods section is available in the online data supplement at http://atvb.ahajournals.org.
Animals Studies
Wild-type C57BL/6, W/Wv(WBB6F1 hybrid strain, c-kit mutant mice), colony control WBB6F1 (+/+), Sl/Sld (Steel-Dickie; WCB6F1 hybrid strain, SCF mutant mice), and colony control WCB6F1 (+/+) mice were purchased from Jackson Labs (Bar Harbor, Me) and were used for the vascular injury studies. All procedures involving experimental animals were performed in accordance with protocols approved by the institutional committees for animal research of Toronto General Hospital, Mount Sinai Hospital, and Chang Gung Memorial Hospital and were conducted according to guidelines of the American Physiological Society.
Mouse Femoral Artery Wire-Injury Model
Femoral arterial injury was induced by inserting a straight spring wire (0.38 mm in diameter, No. C-SF-15-15, Cook) for more than 5 mm toward the iliac artery.13
Cell Culture
Human aortic smooth muscle cells were purchased from Smartec Scientific (Cascade Biologics) and grown in 231 medium with smooth muscle cell growth supplement, plus 50 U/mL penicillin and 50 µg/mL streptomycin in a humidified atmosphere of 5% CO2. More than 97% of the cultured cells were VSMCs as confirmed by immunostaining with a monoclonal 
-smooth muscle actin (SMA) antibody.14 Cells used for the experiments were in the third to fifth passages and were 80% confluent. To produce apoptosis by serum deprivation and H2O2, cells were washed with PBS, the medium was replaced with serum-free medium with H2O2 (800 µmol/L), and the cells were incubated and harvested at the indicated time points. Smooth muscle progenitors,15 endothelial progenitors,16 and late-outgrowth endothelial cells (OECs)16 were also cultured using the standard methods mentioned previously.
Bone Marrow Transplantation Model
Recipient FVB mice at 8 weeks of age were lethally irradiated with a total dose of 9.0 Gy. eGFP transgenic mice (FVB background) that ubiquitously expressed enhanced GFP were used as the donors (Level Biotechnology Inc., Taipei, Taiwan).17 After irradiation, the recipient mice received unfractionated bone marrow cells (5x106) from eGFP mice by tail vein injection. At 8 weeks after the injection, these mice received wire injury to the femoral artery. Repopulation by eGFP-positive bone marrow cells was measured by flow cytometry to be 95%.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Apoptosis Stimulation Upregulates c-kit mRNA Transcription and Protein Expression
After H2O2 stimulation, although there was no significant change in the total caspase-3 amount, caspase-3 was transiently activated as indicated by the amount of cleaved caspase-3 (Figure 1A). The activation of caspase-3 peaked at 0.5 hour and then gradually returned back to the baseline. Apoptosis stimulation also induced a 25-fold increase in the number of apoptotic cells as indicated by Annexin-V+PI– cells (Figure 1B). By RT-PCR and Q-PCR (Figure 1C and 1D, respectively), VSMCs had a low baseline level of c-kit mRNA transcription. In response to apoptosis stimulation, the transcription of c-kit mRNA increased by approximately 5.5-fold (1 hour after H2O2 administration). By Western blotting, c-kit protein expression was present at the baseline and significantly increased after apoptosis stimulation in human VSMCs (Figure 1E) Immunofluorescent staining also demonstrated substantial c-kit expression on Annexin-V+ apoptotic VSMCs (supplemental Figure I). In the in vivo animal model, wire injury activated caspase-3 throughout the entire vessel and stimulated c-kit and cleaved caspase-3 coexpression on medial VSMCs at different time points (Figure 1F). Because the anti-c-kit antibody used in this study (sc-168) maps the cytoplasmic domain of the c-Kit protein (amino acids 925 to 975),18,19 the cytoplasmic staining pattern was observed in the majority of our immunofluorescence images.
|
SCF Attenuates the Activation of Apoptosis
In vitro, SCF (10 to 1000 ng/mL) was administered in VSMCs treated with H2O2. SCF significantly attenuated the amount of cleaved caspase-3 in a dose-dependent manner (Figure 2A). As estimated by flow cytometry, SCF (100 ng/mL) caused a 3-fold decrease in the number of VSMCs with activated caspase-3 (Figure 2B). Using annexin-V to estimate the number of VSMCs undergoing apoptosis, SCF (1000 ng/mL) also significantly lowered the number of apoptotic VSMCs from 24.7%±3.5% to 11.8%±2.7% (P<0.01) (Figure 2C). To clarify whether SCF also has effects on proliferation in VSMCs with apoptotic stimulation, a proliferation assay was performed and showed that SCF significantly increased VSMC proliferation only at a high concentration (1000 ng/mL) (Figure 2D). The in vivo experiments revealed that after the femoral artery had been injured by the wire, SCF expression was greatly upregulated in the adventitia and in surviving medial VSMCs, providing a direct source of SCF for rescuing injured VSMCs (Figure 2E). The upregulated transcription of SCF mRNA at injured sites was also quantified by Q-PCR, which demonstrated a 3.5-fold increase in the SCF mRNA amount on injured vessels 4 days after wire-injury, compared with the baseline.
|
P<0.01, 
P<0.001, compared with the group with H2O2 stimulation, with no SCF treatment (n=6 for each group). Scale bar=50 µm.
C-kit-Positive Cells Help SCF-Positive Cell Homing
Mouse femoral arteries were injured with a wire and then subjected to immunostaining at indicated time points. On days 1 and 3, although remarkable SCF expression was noted in cells in the adventitia, no cells had adhered to the surface of the injured vessel wall (Figure 3A). On day 7 to 9 after vascular injury, many SCF+ cells had accumulated on the surface of the injured vascular wall, close to the sites with c-kit protein expression (Figure 3A and 3B; supplemental Figure II). In the in vitro experiments, SCF expression was investigated in a variety of bone marrow–derived progenitor cells, including smooth muscle progenitors, endothelial progenitors, OECs, and human aortic endothelial cells (supplemental Figure IIIA through IIID). All these cells strongly expressed SCF, as demonstrated by immunofluorescent staining and Western blot analysis (supplemental Figure IIIE).
|
Progenitor cell homing involves cellular adhesion. As mentioned above, OECs strongly expressed SCF. In the adhesion assay, apoptotic VSMCs greatly increased the adhesion of OECs, an interaction that was blocked by administration of the anti-SCF antibody (Figure 3C). Furthermore, a modified Boyden chamber was used to assess the chemoattractive potential of c-kit+ cells to SCF+ OECs. H2O2-stimulated VSMCs, compared with unstimulated VSMCs, induced significantly more OEC migration (Figure 3D). A significant abolishment of this migratory effect by an SCF blockade further supported the chemoattractive ability of c-kit+ cells to SCF+ cells. Similar findings were also repeated with SCF+ smooth muscle progenitors (data not shown). To clarify the related mechanisms, our data demonstrated that H2O2 stimulation upregulated the expression of SCF by VSMCs (supplemental Figure IVA). In a dose-dependent manner, SCF significantly increased the production of VEGF and stroma-derived factor-1 (SDF-1) by VSMCs undergoing apoptotic stimulation (supplemental Figure IVB and IVC). Through the expression of the receptors of VEGF (VEGF-R2) and SDF-1 (CXCR4) on OECs20 and smooth muscle progenitor cells,21 respectively, the migratory ability of these cells toward VSMCs undergoing apoptotic stress substantially increased.
In the in vivo model of wire-induced femoral artery injury in wild-type mice reconstituted with BM cells expressing eGFP (BMTGfp
Wild mice), results showed that smooth muscle progenitor cells expressed SCF in the early phase after attaching to the injured vessel wall but became SCF-negative when they were mature in the neointima (supplemental Figure IIIF and IIIG). Although it is not fully understood how these cells adapt to this environment and how differentiation is coordinated, these cells had high potential to contribute to intimal hyperplasia.
SCF Attenuates Apoptosis Through the Akt-Bcl-2 Pathway
Although there was no significant change in the total Akt amount, treatment with SCF transiently activated Akt, which peaked at 0.5 hour, followed by a significant increase in the amount of Bcl-2 (Figure 4A). The control group revealed a significant increase in the amount of cytosolic cytochrome-c which was maintained at a higher level in response to apoptosis stimulation compared with the baseline (Figure 4B). However, in the SCF treatment group, cytosolic cytochrome-c levels significantly decreased and were maintained at a very low level compared with the control group.
|
Apoptosis in SCF and c-kit Mutant Mice
W/Wv mice are compound heterozygotes of a null c-kit mutation (W), and the W-viable (Wv) allele exhibits reduced kinase activity and represents the severest c-kit mutants that survive gestation. Similarly, Sl/Sld mice are compound heterozygotes of a null SCF mutation (Sl) and the Steel-Dickie (Sld) mutation, which lacks mSCF, and represent the severest SCF mutants that survive gestation. Thus, W/Wv mice have a relative deficiency of c-kit kinase activity, although the affected cells express normal to elevated levels of the c-kit receptor and Steel-Dickie mice have a complete deficiency of membrane-bound SCF.
Intimal hyperplasia was significantly decreased in both SCF mutant and c-kit mutant mice compared with colony control mice (Figure 5A). As estimated by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining, the number of apoptotic cells tended to be higher on the vessel wall in both SCF and c-kit mutant mice compared with the media and adventitia of colony control mice on day 7 after vascular injury (Figure 5C). On day 14, the number of apoptotic cells on the entire vessel wall was significantly higher in both SCF mutant and c-kit mutant mice compared with colony control mice (Figure 5B and 5C). On the other hand, the number of proliferating cells on the vessel wall 7 days after wire injury was significantly lower in SCF mutant and c-kit mutant mice compared with colony control mice (Figure 5D).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
This study demonstrated that the SCF/c-kit system plays a critical role in the mechanisms of vascular remodeling, namely intimal hyperplasia, in response to the early-onset apoptosis in medial VSMCs after injury. The transcription of c-kit mRNA and the expression of c-kit protein by VSMCs were significantly upregulated in response to apoptotic stimulation. The increased c-kit expression on VSMCs not only helps SCF exert its effects through protecting VSMCs from apoptosis and increasing VSMC proliferation but also facilitates the homing process of SCF-positive cells, which contribute to intimal hyperplasia. Furthermore, SCF attenuated the apoptosis of VSMCs through the Akt–Bcl-2 pathway. The SCF/c-kit system orchestrated exacerbation of neointimal formation after vascular injury at least in part by attenuating VSMC apoptosis and provoking a greater wound healing response to overcome the cellular deficit.
Stem cell factor (SCF, Steel Factor) through its cognate receptor, the tyrosine kinase c-kit,6 has been shown to promote survival,7 proliferation,8 mobilization,9 and adhesion10 of a variety of hematopoietic progenitors. Recently, this system was also demonstrated in the vascular system, although its role is still not fully understood. Matsui et al found that SCF improves a variety of biological functions and survival of human umbilical vein endothelial cells.12 Hollenbeck et al showed that this system is expressed by and may affect VSMCs through an autocrine pathway.11 In the present study, we demonstrated that this system also exerts its effect on the exacerbation of intimal hyperplasia through upregulating c-kit expression on apoptotic VSMCs, protecting VSMCs from apoptosis, and increasing VSMC proliferation and homing SCF+ cells. In addition, associated mechanisms and the signaling pathway are also provided.
The consequences of early-onset apoptosis in medial VSMCs after vascular injury have not been fully investigated. VSMC apoptosis has been demonstrated in atherosclerosis and in restenotic lesions after angioplasty. In animal models of balloon vascular injury, medial VSMC apoptosis and subsequent cell loss were observed soon after the injury.13 However, the molecular mechanisms of vascular cell apoptosis remain to be elucidated, and the role of VSMC apoptosis in vascular remodeling is still a matter of controversy.22–25 It has been proposed that VSMC apoptosis prevents proliferative vascular disease,22–25 because forced induction of VSMC apoptosis by gene modification results in a reduction of vascular lesions. In contrast, it has also been postulated that vascular cell apoptosis plays a role in the development of vascular lesions, because exuberant balloon-induced apoptosis results in enhanced neointimal formation.4 As proposed by the current study, this phenomenon can be attributed, at least in part, to the SCF/c-kit system. Our results demonstrated that an apoptosis-stimulating stress substantially upregulated the transcription of c-kit mRNA and the synthesis of c-kit protein. The c-kit receptor is a member of the type III receptor tyrosine kinase family.26 This family of cytokine receptors also encompasses the c-fms receptor, the platelet-derived growth factor receptors, and the flk-2/flt-3 receptor. Specifically, our findings suggest that SCF exerts its antiapoptotic effect through c-kit tyrosine kinase and then Akt, followed by a remarkable increase in the amount of intracellular Bcl-2, leading to a substantial inhibition of the release of cytochrome-c from the mitochondria to the cytosol (Figure 4C). Through this pathway, SCF significantly attenuates the activation of caspase-3 and eventual cellular apoptosis.
On the other hand, the upregulated expression of c-kit receptors on VSMCs undergoing apoptosis not only activated this SCF/c-kit system but also helped SCF-positive cells home in on injured vascular sites. These SCF-positive cells provided a substantial amount of SCF to rescue VSMCs from apoptosis and also substantially contributed to the formation of neointima. The concentration of SCF in normal human serum is, on average, 3.3 ng/mL.26 Our data showed that SCF already exerts its effects at similar concentrations in a dose-dependent manner at higher concentrations. Local SCF concentrations at injured vascular sites, as provided by locally accumulated SCF-expressing cells or bone marrow–derived progenitor cells, are expected to be much higher than serum levels. Consistent with this notion, our findings revealed that smooth muscle progenitor cells, late-outgrowth of endothelial cells, endothelial progenitor cells, and aortic endothelial cells all express SCF. These findings are in line with the new paradigm that bone marrow–derived progenitor cells contribute to intimal hyperplasia after vascular injury, as shown extensively in the literature.16,27,28 However, how the fate of these SCF-positive cells is decided in this microenvironment still remains to be elucidated.
The mouse femoral artery wire-injury model adopted in the present study represents a severe vascular injury model. Although the extent of vascular injury is considerably less severe in human angioplasty, in the era of extensive vascular stent intervention, similar stresses on vessel walls may exist as atherosclerotic plaques are pushed outward. In this study, we also took advantage of SCF-mutant and c-kit mutant mice to gain further support for our hypothesis. In SCF-mutant mice, deficiencies of both mSCF and sSCF disrupted the ability of the SCF/c-kit system to rescue injured VSMCs as indicated by extensive apoptotic events throughout all three layers of the injured vessel wall. Their deficiencies in SCF also substantially attenuated the contribution of SCF-positive cells to the formation of neointima. Although SCF is not deficient in c-kit mutant mice, the lack of appropriate c-kit tyrosine kinase signaling also led to remarkable apoptotic processes on the injured vessel wall, especially on the vascular media and adventitia. Through these mechanisms, these mutant mice ended up with significantly less intimal hyperplasia compared with colony control mice. The effect of SCF in stimulating VSMC proliferation may also contribute to growth of the neointima. However, SCF exerts this effect only at high concentrations.
In summary, we herein demonstrate a novel way by which the SCF/c-kit system works on vascular remodeling processes. These findings illustrate that the SCF/c-kit interaction is a very complicated process. To attenuate intimal hyperplasia or atherosclerotic processes, our work provides a rationale for testing directed therapies aimed at interrupting the SCF/c-kit pathway in patients undergoing vascular interventions such as a bypass graft and angioplasty.
|
Acknowledgments |
|---|
We thank Rei-Chang Chen and Hsiu-Fu Mei for technical assistance with performing the real-time PCR and confocal microscope.
Sources of Funding
This work was supported in part by the National Science Council of Taiwan (NSC 94-2134-B-182A-191 and NSC 94-2134-B-182A-192) and in part by Heart and Stroke Foundation of Canada (to S.V. and R.D.W.).
Disclosures
None.
|
Footnotes |
|---|
This work was presented at the annual meeting of the American Heart Association Scientific Sessions 2005, in Dallas, Texas, November 13–16, 2005
Original received April 15, 2006; final version accepted November 27, 2006.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
- Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis: Part I. Circulation. 2002; 106: 2734–2740.
- Savage MP, Douglas JS, Jr., Fischman DL, Pepine CJ, King SB, III, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med. 1997; 337: 740–747.
[Abstract/Free Full Text] - Han DK, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995; 147: 267–277.[Abstract]
- Rivard A, Luo Z, Perlman H, Fabre JE, Nguyen T, Maillard L, Walsh K. Early cell loss after angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wall. Hum Gene Ther. 1999; 10: 711–721.[CrossRef][Medline] [Order article via Infotrieve]
- Walsh K, Smith RC, Kim HS. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ Res. 2000; 87: 184–188.
[Free Full Text] - Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature. 1988; 335: 88–89.[CrossRef][Medline] [Order article via Infotrieve]
- Domen J, Weissman IL. Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J Exp Med. 2000; 192: 1707–1718.
[Abstract/Free Full Text] - Leary AG, Zeng HQ, Clark SC, Ogawa M. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci U S A. 1992; 89: 4013–4017.
[Abstract/Free Full Text] - Fleming WH, Alpern EJ, Uchida N, Ikuta K, Weissman IL. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci U S A. 1993; 90: 3760–3764.
[Abstract/Free Full Text] - Levesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med. 1995; 181: 1805–1815.
[Abstract/Free Full Text] - Hollenbeck ST, Sakakibara K, Faries PL, Workhu B, Liu B, Kent KC. Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway. J Surg Res. 2004; 120: 288–294.[CrossRef][Medline] [Order article via Infotrieve]
- Matsui J, Wakabayashi T, Asada M, Yoshimatsu K, Okada M. Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem. 2004; 279: 18600–18607.
[Abstract/Free Full Text] - Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, Sugiura S, Aoyagi T, Imai Y, Kurihara H, Kimura K, Omata M, Makuuchi M, Hirata Y, Nagai R. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol. 2000; 32: 2097–2104.[CrossRef][Medline] [Order article via Infotrieve]
- Ozawa T, Mickle DAG, Weisel RD, Koyama N, Ozawa S, Li RK. optimal biomaterial for creation of autologous cardiac grafts. Circulation. 2002; 106 (suppl I): 176I–182I.
- Fukuda D, Sata M, Tanaka K, Nagai R. potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation. 2005; 111: 926–931.
- Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al Omran M, Cherng WJ, Li RK, Stanford WL, Verma S. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation. 2004; 109: 1392–1400.
- Hsiao YC, Chang HH, Tsai CY, Jong YJ, Horng LS, Lin SF, Tsai TF. Coat color-tagged green mouse with EGFP expressed from the RNA polymerase II promoter. Genesis. 2004; 39: 122–129.[CrossRef][Medline] [Order article via Infotrieve]
- Lucas DR, al-Abbadi M, Tabaczka P, Hamre MR, Weaver DW, Mott MJ. c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol. 2003; 119: 339–345.[Medline] [Order article via Infotrieve]
- Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol. 2002; 26: 493–497.[CrossRef][Medline] [Order article via Infotrieve]
- Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation. 2005; 112: 1618–1627.
- Zhang LN, Wilson DW, da Cunha V, Sullivan ME, Vergona R, Rutledge JC, Wang YX. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Arterioscler Thromb Vasc Biol. 2006; 26: 765–772.
[Abstract/Free Full Text] - Fukuo K, Inoue T, Morimoto S, Nakahashi T, Yasuda O, Kitano S, Sasada R, Ogihara T. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. J Clin Invest. 1995; 95: 669–676.[Medline] [Order article via Infotrieve]
- Fukuo K, Nakahashi T, Nomura S, Hata S, Suhara T, Shimizu M, Tamatani M, Morimoto S, Kitamura Y, Ogihara T. Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis. Gerontology. 1997; 43 (Suppl 1): 35–42.
- Cai W, Devaux B, Schaper W, Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis. 1997; 131: 177–186.[CrossRef][Medline] [Order article via Infotrieve]
- Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997; 17: 2200–2208.
[Abstract/Free Full Text] - Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997; 90: 1345–1364.
[Free Full Text] - Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002; 8: 403–409.[CrossRef][Medline] [Order article via Infotrieve]
- Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005; 353: 999–1007.
[Abstract/Free Full Text]
This article has been cited by other articles:
 |
|
 |
|
  C.-H. Wang, W.-J. Cherng, N.-I Yang, C.-M. Hsu, C.-H. Yeh, Y.-J. Lan, J.-S. Wang, and S. Verma Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R811 - R818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Diao, S. Guthrie, S.-L. Xia, X. Ouyang, L. Zhang, J. Xue, P. Lee, M. Grant, E. Scott, and M. S. Segal Long-Term Engraftment of Bone Marrow-Derived Cells in the Intimal Hyperplasia Lesion of Autologous Vein Grafts Am. J. Pathol., March 1, 2008; 172(3): 839 - 848. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||